Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2007
Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Journal of Medicinal Chemistry
|
March 14, 2007
Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors
Zhi-Fu Tao, Le Wang, Kent D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2006
Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors
Gaoquan Li, Lisa A Hasvold, Zhi-Fu Tao, et al.
International Journal of Cancer
|
October 5, 2006
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen, Zhan Xiao, Wen-Zhen Gu, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> Inhibitor
Zhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Journal of Medicinal Chemistry
|
October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases
Zhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailability
Yunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studies
Yunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.
Journal of Medicinal Chemistry
|
July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors
Le Wang, Gerard M Sullivan, Laura A Hexamer, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Bioorganic & Medicinal Chemistry Letters
|
June 5, 2007
Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Journal of Medicinal Chemistry
|
March 14, 2007
Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors
Zhi-Fu Tao, Le Wang, Kent D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2007
Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors
Zhi-Fu Tao, Gaoquan Li, Yunsong Tong, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2006
Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors
Gaoquan Li, Lisa A Hasvold, Zhi-Fu Tao, et al.
International Journal of Cancer
|
October 5, 2006
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics
Zehan Chen, Zhan Xiao, Wen-Zhen Gu, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> Inhibitor
Zhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Journal of Medicinal Chemistry
|
October 22, 2009
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases
Zhi-Fu Tao, Lisa A Hasvold, Joel D Leverson, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailability
Yunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studies
Yunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.
Journal of Medicinal Chemistry
|
July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitors
Le Wang, Gerard M Sullivan, Laura A Hexamer, et al.
Page
of 4